Clinical Trial Update: Adjunctive Vortioxetine in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating adjunctive vortioxetine for schizophrenia with focus on negative symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Negative Symptoms of Schizophrenia
• Schizophrenia

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Northwell Health | Conditions: Schizophrenia, Negative Symptoms | Phase 4 | Status: UNKNOWN